The Motley Fool··Jonathan PoncianoArcutis Stock Surges 65% as Director Sells Shares Under Pre-Planned Trading Strategy
Arcutis director sells 10,000 shares via pre-planned trading arrangement as stock surges 65%. ZORYVE revenue hit $372.1M in 2025, up 123% YoY, with company achieving positive operating cash flow.
ARQTbiopharmaceuticalcommercialization